Search

everythinglearnresearchcommunity

for

Search:↓

Frontal fibrosing alopecia mainly affects postmenopausal women and may be linked to thyroid hormones.

Frontal fibrosing alopecia is a scarring hair loss condition mainly affecting postmenopausal women, with unclear causes.

Frontal Fibrosing Alopecia is a hair loss condition mainly affecting postmenopausal women, with unclear causes and various clinical patterns.

Hirsutism and alopecia during menopause can be diagnosed and treated with specific hormonal and topical therapies.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

A 46-year-old man was diagnosed with frontal fibrosing alopecia, a condition usually seen in postmenopausal women.

Frontal fibrosing alopecia causes hair loss along the frontal hairline, mainly in postmenopausal women, and needs better treatments.

Frontal fibrosing alopecia can occur in children, not just postmenopausal women.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Taking 1 mg of finasteride daily can increase hair count and improve hair appearance, but it may have side effects on sexual function and a potential risk of prostate cancer. It may not be effective for postmenopausal women unless taken in higher doses.

The study concludes that early diagnosis of Frontal Fibrosing Alopecia is important, as it is often found in postmenopausal women, may be related to Lichen Planopilaris, and eyebrow hair loss is a common sign.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

The review suggests more research is needed to understand Frontal fibrosing alopecia, a condition causing hairline recession in postmenopausal women.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

A postmenopausal woman's high testosterone levels and symptoms improved after removing a tumor from her ovary.

A postmenopausal woman's increased male hormone levels were successfully treated with surgery.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

A woman's skin darkened after using dutasteride and pimecrolimus for hair loss, but improved when she stopped the medications and protected her skin from light.

Frontal Fibrosing Alopecia mainly affects postmenopausal women and is linked to thyroid disease, hyperlipidemia, and anemia.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The article concludes that understanding Frontal Fibrosing Alopecia (FFA) is crucial for effective treatment, which includes medication like 5α-reductase inhibitors and hydroxychloroquine.

Leydig cell hyperplasia can cause virilization in postmenopausal women and is treatable with surgery.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Early diagnosis and surgery can improve symptoms of ovarian hyperthecosis in postmenopausal women.

Cosmeceuticals like sunscreens may trigger frontal fibrosing alopecia, but more research is needed.

Frontal fibrosing alopecia is a challenging hair loss condition with no known cause or definitive treatment.

The study found that the average age of women diagnosed with Frontal Fibrosing Alopecia in Argentina is higher than in other countries, but their symptoms are similar.

Upper eyelid hyperpigmentation can help diagnose facial lichen planus pigmentosus in patients with frontal fibrosing alopecia.